Received Feb 19, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| FLU3 | INFLUENZA (SEASONAL) (FLULAVAL) | GLAXOSMITHKLINE BIOLOGICALS | UNK | J5T9Z | — |
Mistaken administration of a FLULAVAL instead of a FLUZONE High Dose; This non-serious case was reported by a nurse via call center representative and described the occurrence of wrong vaccine administered in a 71-year-old female patient who received Flu Seasonal TIV Quebec (FluLaval 2024-2025 season) (batch number J5T9Z, expiry date 06-JUN-2025) for prophylaxis. Co-suspect products included Influenza vaccine inact split 3v (Fluzone high dose) for prophylaxis. On 29-JAN-2025, the patient received FluLaval 2024-2025 season. On an unknown date, the patient received Fluzone high dose. On 29-JAN-2025, an unknown time after receiving FluLaval 2024-2025 season, the patient experienced wrong vaccine administered (Verbatim: Mistaken administration of a FLULAVAL instead of a FLUZONE High Dose). The outcome of the wrong vaccine administered was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 30-JAN-2025 The reporter reported that a patient mistaken administration of a Flulaval instead of a fluzone high dose in a seventy one year old patient which led to wrong vaccine administered. Vaccination date, vaccine detail and patient demographics were provided from the registered nurse end. No further information was obtained in this call.